Pre-made benchmark antibody with INN name
Virus-like particles (VLP) Platforms for immunogens, vaccines and drug carriers
Antibody-drug Conjugate (ADC): Pre-made ADC benchmark, MOA, Production and QC
Neutralizing antibodies of virus (SARS2, HIV, HBV, Rabies, RSV, Ebola, Influenza)
Immunoglobulin Fc receptors for Fc&Fc Receptor binding assay
ILIBRA-HuEasy Monoclonal antibody (mab) humanization service (fully humanized ab)
Single domain antibody (Nanobody)
SOCAIL MEDIA
GeneMedi provides pre-made research class therapeutic antibodies & Fusion Protein with WHO-INN name. The INN named antibodies & Fusion Protein are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody or Fusion Protein for cell culture, in vitro/in vivo assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Link to IMGT(Immunogenetics Information System)
Know more about INN named antibodies
Download about 
INN information from WHO
Product list
Filters
Sort results
Reset
Apply
Cat No. | Products Name (INN Index) | INN Name | Previous Name | Target | Format | Order |
|---|---|---|---|---|---|---|
Pre-Made Ustekinumab biosimilar, Whole mAb, Anti-IL12B Antibody: Anti-CLMF/CLMF2/IL-12B/IMD28/IMD29/NKSF/NKSF2 therapeutic antibody |
Ustekinumab |
NA |
IL12B |
Whole mAb |
||
Pre-Made Utomilumab biosimilar, Whole mAb, Anti-TNFRSF9/CD137 Antibody: Anti-ILA/4-1BB/CDw137 therapeutic antibody |
Utomilumab |
NA |
TNFRSF9 |
Whole mAb |
||
Pre-Made Vadastuximab biosimilar, Whole mAb ADC, Anti-CD33 Antibody: Anti-p67/SIGLEC3/SIGLEC-3 therapeutic antibody |
Vadastuximab |
NA |
CD33 |
Whole mAb ADC |
||
Pre-Made Valanafusp biosimilar, Whole mAb Fusion, Anti-INSR Antibody: Anti-CD220/HHF5 therapeutic antibody |
Valanafusp |
NA |
INSR |
Whole mAb Fusion |
||
Pre-Made Vanalimab biosimilar, Whole mAb, Anti-CD40 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic antibody |
Vanalimab |
mitazalimab |
CD40 |
Whole mAb |
||
Pre-Made Vandortuzumab biosimilar, Whole mAb ADC, Anti-STEAP1 Antibody: Anti-PRSS24/STEAP therapeutic antibody |
Vandortuzumab |
NA |
STEAP1 |
Whole mAb ADC |
||
Pre-Made Vantictumab biosimilar, Whole Mab: Anti-FZD Family therapeutic antibody |
Vantictumab |
NA |
FZD Family |
Whole mAb |
||
Pre-Made Vanucizumab biosimilar, Bispecific mAb, Anti-ANGPT2;VEGFA Antibody: Anti-AGPT2/ANG2/LMPHM10;VPF/VEGF/MVCD1 therapeutic antibody |
Vanucizumab |
NA |
ANGPT2,VEGFA |
Bispecific mAb |
||
Pre-Made Varisacumab biosimilar, Whole mAb, Anti-VEGFA Antibody: Anti-VPF/VEGF/MVCD1 therapeutic antibody |
Varisacumab |
NA |
VEGFA |
Whole mAb |
||
Pre-Made Varlilumab biosimilar, Whole mAb, Anti-CD27 Antibody: Anti-T14/S152/Tp55/TNFRSF7/S152. LPFS2 therapeutic antibody |
Varlilumab |
NA |
CD27 |
Whole mAb |
||
Pre-Made Vatelizumab biosimilar, Whole mAb, Anti-ITGA2 Antibody: Anti-BR/CD49B/GPIa/HPA-5/VLA-2/VLAA2 therapeutic antibody |
Vatelizumab |
NA |
ITGA2 |
Whole mAb |
||
Pre-Made Vedolizumab biosimilar, Whole mAb, Anti-ITGA4;ITGB7 Antibody: Anti-CD49D/IA4 therapeutic antibody |
Vedolizumab |
NA |
ITGA4_ITGB7 |
Whole mAb |
||
Pre-Made Veltuzumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Veltuzumab |
NA |
MS4A1 |
Whole mAb |
||
Pre-Made Vesencumab biosimilar, Whole mAb, Anti-NRP1 Antibody: Anti-BDCA4/CD304/NP1/NRP/VEGF165R therapeutic antibody |
Vesencumab |
NA |
NRP1 |
Whole mAb |
||
Pre-Made Vibecotamab biosimilar, Bispecific Mixed mAb and scFv, Anti-IL3RA;CD3E Antibody: Anti-CD123/IL3RX/IL3RY/IL3RAY/hIL-3Ra;T3E/TCRE/IMD18 therapeutic antibody |
Vibecotamab |
NA |
IL3RA,CD3E |
Bispecific Mixed mAb and scFv |
||
Pre-Made Vibostolimab biosimilar, Whole mAb, Anti-TIGIT Antibody: Anti-VSIG9/VSTM3/WUCAM therapeutic antibody |
Vibostolimab |
NA |
TIGIT |
Whole mAb |
||
Pre-Made Vilobelimab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody |
Vilobelimab |
NA |
C5 |
Whole mAb |
||
Pre-Made Visilizumab biosimilar, Whole mAb, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody |
Visilizumab |
NA |
CD3E |
Whole mAb |
||
Pre-Made Vixarelimab biosimilar, Whole mAb, Anti-OSMR Antibody: Anti-IL-31R-beta/IL-31RB/OSMRB/OSMRbeta/PLCA1 therapeutic antibody |
Vixarelimab |
NA |
OSMR |
Whole mAb |
||
Pre-Made Vixtimotamab biosimilar, Bispecific Homodimer (VK-VH-VL'-VH', Tandem diabody)), Anti-CD3E;CD33 Antibody: Anti-T3E/TCRE/IMD18;p67/SIGLEC3/SIGLEC-3 therapeutic antibody |
Vixtimotamab |
NA |
CD3E,CD33 |
Bispecific Homodimer (VK-VH-VL'-VH', Tandem diabody) |
||
Pre-Made Vobarilizumab biosimilar, Bispecific Single Domains (VH-VH'), Anti-IL6R;ALB Antibody: Anti-CD126/HIES5/IL-1Ra/IL-6R/IL-6R-1/IL-6RA/IL6Q/IL6QTL/IL6RA/IL6RQ/gp80;FDAHT/HSA/PRO0883/PRO0903/PRO1 |
Vobarilizumab |
NA |
IL6R,ALB |
Bispecific Single Domains (VH-VH') |
||
Pre-Made Vofatamab biosimilar, Whole mAb, Anti-FGFR3 Antibody: Anti-ACH/CEK2/JTK4/CD333/HSFGFR3EX therapeutic antibody |
Vofatamab |
NA |
FGFR3 |
Whole mAb |
||
Pre-Made Volagidemab biosimilar, Whole mAb, Anti-GCCR/NR3C1 Antibody: Anti-GCR/GCRST/GR/GRL therapeutic antibody |
Volagidemab |
NA |
GCCR |
Whole mAb |
||
Pre-Made Vonlerolizumab biosimilar, Whole mAb, Anti-TNFRSF4/CD134 Antibody: Anti-ACT35/IMD16/OX40/TXGP1L therapeutic antibody |
Vonlerolizumab |
pogalizumab |
TNFRSF4 |
Whole mAb |
||
Pre-Made Vopratelimab biosimilar, Whole mAb, Anti-ICOS Antibody: Anti-AILIM/CD278/CVID1 therapeutic antibody |
Vopratelimab |
NA |
ICOS |
Whole mAb |
||
Pre-Made Vorsetuzumab biosimilar, Whole mAb ADC, Anti-CD70/CD27-L Antibody: Anti-CD27L/LPFS3/CD27LG/TNFSF7/TNLG8A therapeutic antibody |
Vorsetuzumab |
NA |
CD70 |
Whole mAb ADC |
||
Pre-Made Vudalimab biosimilar, Bispecific Mixed mAb and scFv, Anti-CTLA4/CTLA-4;PDCD1/PD-1 Antibody: Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3;CD279/SLEB2/hPD-1/hPD-l/hSLE1 therapeutic antibody |
Vudalimab |
NA |
CTLA4,PDCD1 |
Bispecific Mixed mAb and scFv |
||
Pre-Made Vulinacimab biosimilar, Whole mAb, Anti-VEGFR2/KDR Antibody: Anti-CD309/FLK1/VEGFR therapeutic antibody |
Vulinacimab |
NA |
VEGFR2 |
Whole mAb |
||
Pre-Made Vunakizumab biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody: Anti-CTLA-8/CTLA8A/ILA17 therapeutic antibody |
Vunakizumab |
NA |
IL17A |
Whole mAb |
||
Pre-Made Xentuzumab biosimilar, Whole mAb, Anti-IGF1;IGF2 Antibody: Anti-IGF/IGF-I/IGFI/MGF;C11orf43/GRDF/IGF-II/PP9974/SRS3 therapeutic antibody |
Xentuzumab |
NA |
IGF1&IGF2 |
Whole mAb |
||
Pre-Made Zagotenemab biosimilar, Whole mAb, Anti-MAPT Antibody: Anti-DDPAC/FTDP-17/MSTD/MTBT1/MTBT2/PPND/PPP1R103/TAU/tau-40 therapeutic antibody |
Zagotenemab |
NA |
MAPT |
Whole mAb |
||
Pre-Made Zalifrelimab biosimilar, Whole mAb, Anti-CTLA4/CTLA-4 Antibody: Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody |
Zalifrelimab |
NA |
CTLA4 |
Whole mAb |
||
Pre-Made Zalutumumab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody |
Zalutumumab |
NA |
EGFR |
Whole mAb |
||
Pre-Made Zampilimab biosimilar, Whole mAb, Anti-TGM2/TG2 Antibody: Anti-G(h)/TG(C)/TGC/hTG2/tTG therapeutic antibody |
Zampilimab |
NA |
TGM2 |
Whole mAb |
||
Pre-Made Zanidatamab biosimilar, Bispecific mAb, Anti-ERBB2/HER2;ERBB2/HER2 Antibody: Anti-CD340/HER-2/MLN 19/NEU/NGL/TKR1/VSCN2;CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody |
Zanidatamab |
NA |
ERBB2,ERBB2 |
Bispecific/biparatopic |
||
Pre-Made Zanolimumab biosimilar, Whole mAb, Anti-CD4 Antibody: Anti-IMD79/OKT4D therapeutic antibody |
Zanolimumab |
NA |
CD4 |
Whole mAb |
||
Pre-Made Zansecimab biosimilar, Whole mAb, Anti-ANGPT2 Antibody: Anti-AGPT2/ANG2/LMPHM10 therapeutic antibody |
Zansecimab |
NA |
ANGPT2 |
Whole mAb |
||
Pre-Made Zatuximab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody |
Zatuximab |
modotuximab |
EGFR |
Whole mAb |
||
Pre-Made Zelminemab biosimilar, Whole mAb, Anti-ADCYAP1R1/PAC1R Antibody: Anti-PAC1/PACAPR/PACAPRI therapeutic antibody |
Zelminemab |
NA |
ADCYAP1R1 |
Whole mAb |
||
Pre-Made Zeluvalimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody |
Zeluvalimab |
NA |
PDCD1 |
Whole mAb |
||
Pre-Made Zenocutuzumab biosimilar, Bispecific mAb, Anti-ERBB3/Erbb-3;ERBB2/HER2 Antibody: Anti-FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3;CD340/neu/MLN 19/NEU/NG |
Zenocutuzumab |
NA |
ERBB3,ERBB2 |
Bispecific mAb |
||
Pre-Made Ziltivekimab biosimilar, Whole mAb, Anti-IL6 Antibody: Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6 therapeutic antibody |
Ziltivekimab |
NA |
IL6 |
Whole mAb |
||
Pre-Made Zilovertamab biosimilar, Whle mAb, Anti-ROR1 Antibody: Anti-NTRKR1/dJ537F10.1 therapeutic antibody |
Zilovertamab |
NA |
ROR1 |
Whole mAb |
||
Pre-Made Zimberelimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody |
Zimberelimab |
NA |
PDCD1 |
Whole mAb |
||
Pre-Made Zolbetuximab biosimilar, Whole mAb, Anti-CLDN18 Antibody: Anti-SFTA5/SFTPJ therapeutic antibody |
Zolbetuximab |
Claudiximab |
CLDN18 |
Whole mAb |
||
Pre-Made Zolimomab biosimilar, Whole mAb, Anti-CD5 Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody |
Zolimomab |
NA |
CD3E |
Whole mAb |
||
Pre-Made Zuberitamab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Zuberitamab |
NA |
MS4A1 |
Whole mAb |
||
Pre-Made Adintrevimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike therapeutic antibody |
Adintrevimab |
NA |
SARS-CoV-2 Spike |
Whole mAb |
||
Pre-Made Amubarvimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Amubarvimab |
NA |
SARS-CoV-2 Spike RBD |
Whole mAb |
||
Pre-Made Anselamimab biosimilar, Whole mAb, Anti-SAA1 Antibody: Anti-PIG4/SAA/SAA2/TP53I4 therapeutic antibody |
Anselamimab |
NA |
SAA1 |
Whole mAb |
